Dr. Matthew Brendan McCarra, MD

Dr. McCarra practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. McCarra's NPI, 1790049567, was assigned on June 26, 2012. Dr. McCarra graduated from University of Minnesota Medical School in 2012. Dr. McCarra's California license number on file is A127426.

Dr. McCarra's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. McCarra's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. McCarra is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. McCarra to 2 more hospitals and 3 medical groups, each named with a free account. Dr. McCarra's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCarra practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. McCarra's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. McCarra is board certified in critical care medicine by the American Board of Internal Medicine. Dr. McCarra has a license on file in California.

Dmand AI lists aneurysm, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), pneumonia and pulmonary fibrosis among the conditions Dr. McCarra treats.

CMS data shows 70 Medicare services from Dr. McCarra across 3 procedure codes in 2024, all of them office visits, for 95 Medicare patients. Medicare paid $8,117 for them.

CMS counts 95 Medicare patients who saw Dr. McCarra in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McCarra's median patient age at 67, with 48% women.

In 2024, Dr. McCarra wrote 43 Medicare Part D claims for 13 patients. 51% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $19,733 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. McCarra for performance year 2024, reported as part of a group. Dr. McCarra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McCarra as offering telehealth.

Dmand AI links 7 papers to Dr. McCarra, published from 2012 to 2023. 2012 was the busiest year, with 2. The most frequent topics are Kenya and Malaria, Falciparum. Dr. McCarra's most frequent co-authors are Chandy C. John, MD, Arlene E. Dent, MD and Aiman Alassar, MD, PhD.

CMS Open Payments shows 2 general payments to Dr. McCarra from 2 drug and device companies from 2019 to 2025. Education make up the largest share, 82% of the total. Genentech, Inc. paid the most, $100.

Dr. McCarra graduated from University of Minnesota Medical School in 2012.

Dr. McCarra is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.